Carbamazepine
Rank #294 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$40.4M
Total Cost
389,090
Total Claims
$40.4M
Total Cost
16,351
Prescribers
$104
Cost per Claim
11,700
Beneficiaries
519,029
30-Day Fills
$2,470
Avg Cost/Provider
24
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$40.4M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $40.4M total
Top Prescribers of Carbamazepine
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Michael Kaplowitz | Psychiatry | Riverdale, NY | 285 | $96K |
| 2 | Deborah Zielinski | Nurse Practitioner | Chicago, IL | 115 | $69K |
| 3 | Caitlin Mcelroy-Cox | Nurse Practitioner | New York, NY | 40 | $58K |
| 4 | Deborah Zielinski | Nurse Practitioner | Chicago, IL | 336 | $54K |
| 5 | James Tao | Neurology | Chicago, IL | 65 | $47K |
| 6 | Melissa Carran | Neurology | Camden, NJ | 183 | $44K |
| 7 | Ruth Dekker | Nurse Practitioner | Pocatello, ID | 206 | $40K |
| 8 | Vijay Thadani | Neurology | Lebanon, NH | 188 | $39K |
| 9 | David Labiner | Neurology | Tucson, AZ | 149 | $39K |
| 10 | Nicole Lawson | Nurse Practitioner | Rochester, MN | 154 | $38K |
| 11 | Stephan Eisenschenk | Neurology | Gainesville, FL | 20 | $37K |
| 12 | Jenell Mitteness | Nurse Practitioner | Willmar, MN | 186 | $36K |
| 13 | Antoine Mitri | Neurology | Downey, CA | 363 | $36K |
| 14 | Hoover Royals | Family Practice | Dover, NC | 471 | $35K |
| 15 | Mubashir Khan | Neurology | Prince George, VA | 168 | $34K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 291 | Atogepant (Qulipta) | $40.7M | 32,955 |
| 292 | Obeticholic Acid (Ocaliva) | $40.6M | 4,131 |
| 293 | Doxycycline Hyclate (Doxycycline Hyclate) | $40.5M | 2,023,357 |
| 294 | Carbamazepine (Carbamazepine) | $40.4M | 389,090 |
| 295 | Methylnaltrexone Bromide (Relistor) | $39.8M | 16,356 |
| 296 | Spironolactone (Spironolactone) | $39.4M | 3,126,938 |
| 297 | Varenicline Tartrate (Varenicline Tartrate) | $38.8M | 87,274 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology